SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-305677
Filing Date
2014-08-12
Accepted
2014-08-12 07:23:55
Documents
14
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d731863d10q.htm 10-Q 677240
2 EX-10.4 d731863dex104.htm EX-10.4 35345
3 EX-10.5 d731863dex105.htm EX-10.5 10072
4 EX-31.1 d731863dex311.htm EX-31.1 7803
5 EX-31.2 d731863dex312.htm EX-31.2 7777
6 EX-32.1 d731863dex321.htm EX-32.1 4123
7 EX-32.2 d731863dex322.htm EX-32.2 4083
14 GRAPHIC g731863ima1.jpg GRAPHIC 112463
  Complete submission text file 0001193125-14-305677.txt   4422221

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cnce-20140630.xml EX-101.INS 526698
9 XBRL TAXONOMY EXTENSION SCHEMA cnce-20140630.xsd EX-101.SCH 38968
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnce-20140630_cal.xml EX-101.CAL 56933
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnce-20140630_def.xml EX-101.DEF 132037
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20140630_lab.xml EX-101.LAB 343156
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20140630_pre.xml EX-101.PRE 259862
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 141032417
SIC: 2834 Pharmaceutical Preparations